ENTRY       D00341                      Drug
NAME        Hydroxyurea (USP);
            Hydroxycarbamide (JAN/INN);
            Droxia (TN);
            Hydrea (TN);
            Siklos (TN)
PRODUCT     DROXIA (E.R. Squibb & Sons)
            DROXIA (H2-Pharma LLC)
            HYDREA (E.R. Squibb & Sons)
            HYDREA (H2-Pharma LLC)
            SIKLOS (Medunik)
  GENERIC   HYDROXYUREA (American Health Packaging)
            HYDROXYUREA (AvKARE)
            HYDROXYUREA (Cardinal Health 107)
            HYDROXYUREA (Cardinal Health 107)
            HYDROXYUREA (Golden State Medical Supply)
            HYDROXYUREA (Leading Pharma)
            HYDROXYUREA (Major Pharmaceuticals)
            HYDROXYUREA (Marlex Pharmaceuticals)
            HYDROXYUREA (Par Pharmaceutical)
            HYDROXYUREA (REMEDYREPACK)
            HYDROXYUREA (REMEDYREPACK)
            HYDROXYUREA (Teva Pharmaceuticals USA)
FORMULA     CH4N2O2
EXACT_MASS  76.0273
MOL_WEIGHT  76.0547
REMARK      Same as: C07044
            Therapeutic category: 4229
            ATC code: L01XX05
            Product: D00341<JP/US>
EFFICACY    Antineoplastic, Antimetabolite
  DISEASE   Chronic myeloid leukemia [DS:H00004]
            Squamous cell carcinomas of the head and neck [DS:H02420]
            Sickle cell anemia [DS:H00229]
TARGET      RRM2 [HSA:6241] [KO:K10808]
  PATHWAY   hsa00230(6241)  Purine metabolism
            hsa00240(6241)  Pyrimidine metabolism
            hsa00480(6241)  Glutathione metabolism
            hsa04115(6241)  p53 signaling pathway
INTERACTION  
STR_MAP     map07041  Antineoplastics - antimetabolic agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX05 Hydroxycarbamide
                  D00341  Hydroxyurea (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antineoplastics, Other
               Hydroxyurea
                D00341  Hydroxyurea (USP)
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Hydroxyurea
               D00341  Hydroxyurea (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               422  Antimetabolites
                4229  Others
                 D00341  Hydroxyurea (USP); Hydroxycarbamide (JAN/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Ribonucleoside-diphosphate reductase
                RRM2
                 D00341  Hydroxyurea (USP) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00341
DBLINKS     CAS: 127-07-1
            PubChem: 7847407
            ChEBI: 44423
            PDB-CCD: NHY
            LigandBox: D00341
            NIKKAJI: J2.937H
ATOM        5
            1   C5a C    25.2773  -18.3400
            2   N1b N    26.4812  -19.0436
            3   N1a N    24.0675  -19.0436
            4   O5a O    25.2773  -16.9385
            5   O1b O    27.6967  -18.3400
BOND        4
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     2   5 1
///
